(Q64610839)
Statements
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy (English)
0 references
18 July 2014
0 references
28 October 2016
0 references
943
0 references
18 year
0 references